Wells Fargo & Company Biolife Solutions Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Biolife Solutions Inc stock. As of the latest transaction made, Wells Fargo & Company holds 99,171 shares of BLFS stock, worth $2.68 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,171

Previous 104,285 4.9%

Holding current value

$2.68 Million

Previous $2.23 Million 11.1%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$19.19 - $26.52 $98,137 - $135,623	-5,114 Reduced 4.9%	99,171 $2.48 Million
Q2 2024 Aug 13, 2024	BUY	$15.14 - $22.99 $542,375 - $823,593	35,824 Added 52.33%	104,285 $2.23 Million
Q1 2024 May 10, 2024	BUY	$15.35 - $18.82 $909,978 - $1.12 Million	59,282 Added 645.84%	68,461 $1.27 Million
Q4 2023 Feb 09, 2024	BUY	$8.99 - $16.86 $18,672 - $35,018	2,077 Added 29.25%	9,179 $149,000
Q3 2023 Nov 13, 2023	SELL	$10.81 - $22.96 $100,878 - $214,262	-9,332 Reduced 56.78%	7,102 $98,000
Q2 2023 Aug 15, 2023	BUY	$17.19 - $24.34 $145,066 - $205,405	8,439 Added 105.55%	16,434 $363,000
Q1 2023 May 12, 2023	BUY	$17.67 - $26.07 $121,887 - $179,830	6,898 Added 628.81%	7,995 $173,000
Q4 2022 Feb 13, 2023	SELL	$16.95 - $25.07 $19,763 - $29,231	-1,166 Reduced 51.52%	1,097 $19,000
Q3 2022 Nov 14, 2022	SELL	$14.64 - $26.7 $28,138 - $51,317	-1,922 Reduced 45.93%	2,263 $52,000
Q2 2022 Aug 12, 2022	SELL	$10.54 - $24.2 $44,689 - $102,608	-4,240 Reduced 50.33%	4,185 $57,000
Q1 2022 May 16, 2022	SELL	$20.81 - $37.29 $113,685 - $203,715	-5,463 Reduced 39.34%	8,425 $192,000
Q4 2021 Feb 14, 2022	SELL	$32.99 - $58.55 $101,939 - $180,919	-3,090 Reduced 18.2%	13,888 $517,000
Q3 2021 Nov 15, 2021	SELL	$42.03 - $60.5 $12,777 - $18,392	-304 Reduced 1.76%	16,978 $719,000
Q2 2021 Aug 16, 2021	SELL	$29.51 - $44.62 $6,167 - $9,325	-209 Reduced 1.19%	17,282 $768,000
Q1 2021 May 13, 2021	SELL	$32.95 - $44.24 $915,449 - $1.23 Million	-27,783 Reduced 61.37%	17,491 $629,000
Q4 2020 Feb 09, 2021	SELL	$27.5 - $45.75 $892,265 - $1.48 Million	-32,446 Reduced 41.75%	45,274 $1.81 Million
Q3 2020 Nov 05, 2020	BUY	$16.04 - $28.94 $136,067 - $245,498	8,483 Added 12.25%	77,720 $2.25 Million
Q2 2020 Aug 13, 2020	BUY	$9.2 - $17.06 $1,738 - $3,224	189 Added 0.27%	69,237 $1.13 Million
Q1 2020 May 14, 2020	BUY	$8.36 - $17.03 $577,241 - $1.18 Million	69,048 New	69,048 $656,000

Others Institutions Holding BLFS

# of Institutions

199

Shares Held

45M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.16B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Biolife Solutions Inc Transaction History